Repeat prescribing safety survey.


Journal

Journal of primary health care
ISSN: 1172-6156
Titre abrégé: J Prim Health Care
Pays: Australia
ID NLM: 101524060

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 03 03 2019
accepted: 19 07 2019
entrez: 16 3 2020
pubmed: 17 3 2020
medline: 18 9 2020
Statut: ppublish

Résumé

INTRODUCTION Repeat prescribing is an accepted part of general practice activities in New Zealand and in many developed countries. However, there has been little research on how this service is used in New Zealand, or on clinicians' attitudes towards it. AIM To discover the opinions of vocationally registered general practitioners (GPs) and general practice registrars regarding repeat prescribing, availability of practice policy and mechanisms for issuing such prescriptions. METHODS A survey was developed by an expert group and shared through the Royal New Zealand College of General Practitioners' (the College) weekly newsletter, epulse, inviting members to participate in the survey. The survey was also emailed to registrars. RESULTS In total, 144 vocationally registered GPs and 115 registrars responded (n=259), giving a response rate of 3.2% for GPs and 12.7% for registrars. Patient convenience and time efficiency for the practice were the most commonly cited reasons for repeat prescribing. Registrars had low awareness of practice policy on repeat prescribing and only one-quarter of practices had an orientation pack that contained advice on repeat prescribing. DISCUSSION Better practice systems are likely to improve the safety profile of repeat prescribing and should be addressed. There is substantial unwanted variability currently in these practice systems.

Identifiants

pubmed: 32171377
pii: HC19019
doi: 10.1071/HC19019
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-248

Auteurs

Steven Lillis (S)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand; and Corresponding author. Email: steven.lillis@outlook.co.nz.

Nicki Macklin (N)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand.

Michael Thorn (M)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand.

Emma Wicks (E)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand.

Kristin Good (K)

Accident Compensation Corporation, PO Box 242, Wellington, New Zealand.

Liza Lack (L)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand.

Richard Medlicott (R)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand.

Catherine Proffitt (C)

PHARMAC, PO Box 10254, Wellington, New Zealand.

Helen Rodenburg (H)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand.

Vanessa Souter (V)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand.

Pam Duncan (P)

Pharmacy Council of New Zealand, PO Box 25137, Wellington, New Zealand.

Lucia Bercinskas (L)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand.

Stephanie Fletcher (S)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand.

Alison Molloy (A)

Royal New Zealand College of General Practitioners, PO Box 10440, Wellington, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH